Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hermans

Showing results (91-100 of 364) with videos related to

Pageof 37
Sort By:
Journal of Diabetes and Its Complications|December 21, 2013
Parental brevity linked to cardiometabolic risk in diabetic descendantsMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|October 29, 1997
Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking BelgiumM Buysschaert, I Paris, P Selvais, et al.
Diabetes Care|March 29, 2003
Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetesMartin Buysschaert, Ihab Joudi, Pierre Wallemacq, et al.
The Biochemical Journal|August 15, 1988
Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse isletsM C Garcia, M P Hermans, J C Henquin
Diabetes & Metabolism|April 15, 2018
Lipoprotein(a) levels are doubled in left-handed patients with diabetesM P Hermans, S A Ahn, M F Rousseau
Journal of Diabetes and Its Complications|April 24, 2012
The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes Care|June 1, 1994
Heart rate and blood pressure variations are unaffected in early microalbuminuric type I diabetic subjectsM P Hermans, P L Selvais, J M Ketelslegers
Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|May 8, 2010
Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivityV Preumont, M-P Hermans, S Brichard, et al.
Cardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Pageof 37

Showing results (91-100 of 364) with videos related to

Sort By:
Pageof 37
Journal of Diabetes and Its Complications|December 21, 2013
Parental brevity linked to cardiometabolic risk in diabetic descendantsMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|October 29, 1997
Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking BelgiumM Buysschaert, I Paris, P Selvais, et al.
Diabetes Care|March 29, 2003
Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetesMartin Buysschaert, Ihab Joudi, Pierre Wallemacq, et al.
The Biochemical Journal|August 15, 1988
Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse isletsM C Garcia, M P Hermans, J C Henquin
Diabetes & Metabolism|April 15, 2018
Lipoprotein(a) levels are doubled in left-handed patients with diabetesM P Hermans, S A Ahn, M F Rousseau
Journal of Diabetes and Its Complications|April 24, 2012
The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes Care|June 1, 1994
Heart rate and blood pressure variations are unaffected in early microalbuminuric type I diabetic subjectsM P Hermans, P L Selvais, J M Ketelslegers
Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|May 8, 2010
Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivityV Preumont, M-P Hermans, S Brichard, et al.
Cardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Pageof 37